Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
48.23
-2.23 (-4.42%)
Aug 11, 2025, 3:23 PM - Market open
Paramount Global Market Cap
Akero Therapeutics has a market cap or net worth of $3.86 billion as of August 11, 2025. Its market cap has increased by 108.01% in one year.
Market Cap
3.86B
Enterprise Value
2.80B
1-Year Change
108.01%
Ranking
Category
Stock Price
$48.23
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from $495.47M to $3.86B, an increase of 678.63%. That is a compound annual growth rate of 39.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 4.02B | 107.15% |
| Dec 31, 2024 | 1.94B | 49.28% |
| Dec 29, 2023 | 1.30B | -49.24% |
| Dec 30, 2022 | 2.56B | 247.29% |
| Dec 31, 2021 | 737.89M | -17.63% |
| Dec 31, 2020 | 895.82M | 41.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |